- Home
- ARCT vs DSU Comparison
ARCT vs DSU Comparison
Compare ARCT & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- DSU
- Stock Information
- Founded
- ARCT 2013
- DSU 1998
- Country
- ARCT United States
- DSU United States
- Employees
- ARCT N/A
- DSU N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- DSU Finance Companies
- Sector
- ARCT Health Care
- DSU Finance
- Exchange
- ARCT Nasdaq
- DSU Nasdaq
- Market Cap
- ARCT 444.5M
- DSU 519.1M
- IPO Year
- ARCT N/A
- DSU N/A
- Fundamental
- Price
- ARCT $13.08
- DSU $10.03
- Analyst Decision
- ARCT Strong Buy
- DSU
- Analyst Count
- ARCT 7
- DSU 0
- Target Price
- ARCT $57.80
- DSU N/A
- AVG Volume (30 Days)
- ARCT 451.8K
- DSU 148.2K
- Earning Date
- ARCT 05-07-2025
- DSU 01-01-0001
- Dividend Yield
- ARCT N/A
- DSU 10.06%
- EPS Growth
- ARCT N/A
- DSU N/A
- EPS
- ARCT N/A
- DSU N/A
- Revenue
- ARCT $152,310,000.00
- DSU N/A
- Revenue This Year
- ARCT N/A
- DSU N/A
- Revenue Next Year
- ARCT $39.21
- DSU N/A
- P/E Ratio
- ARCT N/A
- DSU N/A
- Revenue Growth
- ARCT N/A
- DSU N/A
- 52 Week Low
- ARCT $8.04
- DSU $9.22
- 52 Week High
- ARCT $45.00
- DSU $11.40
- Technical
- Relative Strength Index (RSI)
- ARCT 60.60
- DSU 47.04
- Support Level
- ARCT $10.07
- DSU $9.82
- Resistance Level
- ARCT $11.00
- DSU $10.06
- Average True Range (ATR)
- ARCT 0.89
- DSU 0.26
- MACD
- ARCT 0.53
- DSU 0.03
- Stochastic Oscillator
- ARCT 100.00
- DSU 78.44
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About DSU Blackrock Debt Strategies Fund Inc.
Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.